Stage IV Intrahepatic Cholangiocarcinoma AJCC v8 Clinical Trials

13 clinical trials for Stage IV Intrahepatic Cholangiocarcinoma AJCC v8 across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases — RECRUITING · PHASE1
• Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer — RECRUITING · PHASE1
• Radioembolization With Tremelimumab and Durvalumab for Locally Advanced Unresectable or Oligo-Metastatic Intrahepatic Cholangiocarcinoma — RECRUITING · PHASE1
• Testing the Addition of Ivonescimab Combined With Standard Chemotherapy Compared to the Usual Chemotherapy and Immunotherapy Treatment for Patients With Advanced Biliary Tract Cancer — NOT_YET_RECRUITING · PHASE2
• Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial) — ACTIVE_NOT_RECRUITING · PHASE2
• Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver — ACTIVE_NOT_RECRUITING · PHASE2
• mFOLFIRINOX Followed by Hepatic Arterial Infusion of Floxuridine and Dexamethasone With Systemic mFOLFIRI for Unresectable Liver-dominant Intrahepatic Cholangiocarcinoma — TERMINATED · PHASE2
• Hypofractionated Radiation Therapy and Bintrafusp Alfa for the Treatment of Advanced Intrahepatic Cholangiocarcinoma — ACTIVE_NOT_RECRUITING · PHASE1
• Sacituzumab Govitecan for the Treatment for Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma — ACTIVE_NOT_RECRUITING · PHASE2
• Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers — COMPLETED · PHASE3
• NXP800 for the Treatment of Patients With Advanced or Metastatic Cholangiocarcinoma — TERMINATED · PHASE1
• Testing A New Combination of Anti-cancer Immune Therapies, Atezolizumab and CDX-1127 (Varlilumab) With or Without the Addition of a Third Anti-cancer Drug, Cobimetinib, for Advanced-Stage Biliary Tract Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Atezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed by Surgery or Gallbladder Cancer — COMPLETED · PHASE2

Refine this search